IP Library Granted Patent US 12,693,255
Granted Patent B2
US 12,693,255 · App. 16/582,583 · Granted Jul 28, 2026

Analyte sensors and sensing methods for detecting creatinine

Inventors: Tianmei Ouyang (Fremont, CA); Benjamin J. Feldman (Berkeley, CA); Hyun Cho (Berkeley, CA)
Assignee: Abbott Diabetes Care Inc.
G01N27/3271A61B5/1451A61B5/14532A61B5/14546A61B5/14735A61B5/1486A61B5/14865C12Q1/002C12Q1/005C12Q1/006G01N27/327A61B2562/02C12Y101/03004C12Y105/03001C12Y305/0201C12Y305/03003G01N2333/904G01N2333/90683G01N2333/978G01N2333/986
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,693,255
App. No.
16/582,583
Filed
Sep 25, 2019
Granted
Jul 28, 2026
Kind
B2
Art Unit
3791
USPC
600/345
Abstract

Creatinine levels may be monitored as a measure of kidney function. Conventionally, blood and/or urine tests are used for this purpose. Analyte sensors capable of monitoring creatinine in vivo may comprise: a sensor tail comprising at least a first working electrode, a creatinine-responsive active area disposed upon a surface of the first working electrode, a first membrane that is permeable to creatinine and overcoats the creatinine-responsive active area, and an oxygen scavenger located upon the sensor tail in proximity to the creatinine-responsive active area. The creatinine-responsive active area comprises a first electron transfer agent, a first polymer, and an enzyme system comprising multiple enzymes, particularly creatinine amidohydrolase, creatine amidinohydrolase, and sarcosine oxidase, that are capable of acting in concert to facilitate detection of creatinine. An oxidase enzyme may serve as the oxygen scavenger, particularly glucose oxidase when detecting creatinine in fluids also containing glucose.

Claims (46)

1 . An analyte sensor comprising:

at least a first working electrode;

a creatinine-responsive active area disposed on a distal end of the first working electrode, the creatinine-responsive active area comprising a first electron transfer agent, a first polymer, and an enzyme system comprising multiple enzymes that are capable of acting in concert to facilitate detection of creatinine, the enzyme system comprising:

creatinine amidohydrolase,

creatine amidinohydrolase, and

sarcosine oxidase;

a dielectric layer covering the first working electrode other than the distal end of the first working electrode;

a first membrane that is permeable to creatinine and overcoats the creatinine-responsive active area, the first membrane comprising polyvinylpyridine-co-styrene; and

an area for oxygen scavenging disposed upon the first membrane and isolated from the first working electrode, the area for oxygen scavenging comprising glucose oxidase as an oxygen scavenger,

wherein the sensor is configured to be partially inserted into a tissue such that a distal portion of the sensor is in contact with an interstitial fluid to detect creatinine in vivo.

2 . The analyte sensor of claim 1 , wherein the area for oxygen scavenging further comprises a second polymer and the glucose oxidase is covalently bonded to the second polymer.

3 . The analyte sensor of claim 1 , wherein the creatinine amidohydrolase, the creatine amidinohydrolase, and the sarcosine oxidase are each covalently bonded to the first polymer.

4 . The analyte sensor of claim 1 , further comprising:

a second working electrode;

a glucose-responsive active area disposed upon a surface of the second working electrode, the glucose-responsive active area comprising a second electron transfer agent, a third polymer, and glucose oxidase that is covalently bonded to the third polymer; and

a second membrane that is permeable to glucose and overcoats the glucose-responsive active area.

5 . The analyte sensor of claim 4 , wherein the first membrane and the second membrane are compositionally the same.

6 . An analyte sensor comprising:

a first working electrode and a second working electrode;

a creatinine-responsive active area disposed on a distal end of the first working electrode, the creatinine-responsive active area comprising a first electron transfer agent, a first polymer, and an enzyme system comprising multiple enzymes that are capable of acting in concert to facilitate detection of creatinine, the enzyme system comprising:

creatinine amidohydrolase,

creatine amidinohydrolase, and

sarcosine oxidase;

a dielectric layer covering the first working electrode other than the distal end of the first working electrode;

a first membrane that is permeable to creatinine and overcoats the creatinine-responsive active area, the first membrane comprising polyvinylpyridine-co-styrene;

an area for oxygen scavenging disposed upon the first membrane and isolated from the first working electrode, the area for oxygen scavenging comprising a second polymer and glucose oxidase as an oxygen scavenger, the glucose oxidase covalently bonded to the second polymer;

a glucose-responsive active area disposed upon a surface of the second working electrode, the glucose-responsive active area comprising a second electron transfer agent, a third polymer, and glucose oxidase that is covalently bonded to the third polymer; and

a second membrane that is permeable to glucose and overcoats the glucose-responsive active area,

wherein the sensor is configured to be partially inserted into a tissue such that a distal portion of the sensor is in contact with an interstitial fluid to detect glucose and creatinine in vivo.

7 . The analyte sensor of claim 6 , wherein the area for oxygen scavenging is overcoated by a third membrane that is also permeable to creatinine.

8 . The analyte sensor of claim 7 , wherein the first membrane, the second membrane and the third membrane are compositionally the same.

9 . The analyte sensor of claim 6 , wherein the first membrane and the second membrane are compositionally the same.

10 . The analyte sensor of claim 6 , wherein the creatinine amidohydrolase, the creatine amidinohydrolase, and the sarcosine oxidase are each covalently bonded to the first polymer.

11 . A method comprising:

exposing the analyte sensor of claim 1 to a fluid comprising at least creatinine;

applying a potential to the first working electrode;

obtaining a first signal at or above an oxidation-reduction potential of the creatinine-responsive active area, the first signal being proportional to a concentration of creatinine in the fluid; and

correlating the first signal to the concentration of creatinine in the fluid.

12 . The method of claim 11 , wherein the creatinine amidohydrolase, the creatine amidinohydrolase, and the sarcosine oxidase are each covalently bonded to the first polymer.

13 . The method of claim 11 , wherein the area for oxygen scavenging further comprises a second polymer and the glucose oxidase is covalently bonded to the second polymer.

14 . The method of claim 12 , wherein the sensor further comprises a second working electrode having a glucose-responsive active area disposed upon a surface of the second working electrode, the glucose-responsive active area comprising a second electron transfer agent, a third polymer, and glucose oxidase that is covalently bonded to the third polymer, the method further comprising:

applying a potential to the second working electrode;

obtaining a second signal at or above an oxidation-reduction potential of the glucose-responsive active area, the second signal being proportional to a concentration of glucose in the fluid; and

correlating the second signal to the concentration of glucose in the fluid.

15 . The method of claim 14 , wherein the first signal and the second signal are obtained at different times.

16 . The method of claim 14 , wherein the first signal and the second signal are obtained simultaneously via a first channel and a second channel.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2019
From: OUYANG, TIANMEI; FELDMAN, BENJAMIN J.; CHO, HYUN
To: ABBOTT DIABETES CARE INC.
Reel/Frame 050900/0723 →
Continuity (4)
Provisional Application 62884869 · Aug 9, 2019
Provisional Application 62884841 · Aug 9, 2019
Provisional Application 62797566 · Jan 28, 2019
Related Publication 20200241015A1 · Jul 30, 2020
References Cited (321)
US 4321123A · Nakamura et al. · 1982 [cited by applicant]
US 4721677A · Clark, Jr. · 1988 [cited by applicant]
US 5262035A · Gregg et al. · 1993 [cited by applicant]
US 5264105A · Gregg et al. · 1993 [cited by applicant]
US 5322063A · Allen et al. · 1994 [cited by applicant]
US 5356786A · Heller et al. · 1994 [cited by applicant]
US 5593852A · Heller et al. · 1997 [cited by applicant]
US 5696314A · McCaffrey et al. · 1997 [cited by applicant]
US 5783056A · Hampp et al. · 1998 [cited by applicant]
US 5792621A · Verostko et al. · 1998 [cited by applicant]
US 5793621A · Yamada · 1998 [cited by applicant]
US 5820551A · Hill et al. · 1998 [cited by applicant]
US 5965105A · Rayalu et al. · 1999 [cited by applicant]
US 5965106A · Pomato et al. · 1999 [cited by applicant]
US 6071391A · Gotoh et al. · 2000 [cited by applicant]
US 6121009A · Heller et al. · 2000 [cited by applicant]
US 6134461A · Say et al. · 2000 [cited by applicant]
US 6175752B1 · Say et al. · 2001 [cited by applicant]
US 6241863B1 · Monbouquette · 2001 [cited by applicant]
US 6284478B1 · Heller et al. · 2001 [cited by applicant]
US 6377894B1 · Deweese et al. · 2002 [cited by applicant]
US 6503381B1 · Gotoh et al. · 2003 [cited by applicant]
US 6514460B1 · Fendrock · 2003 [cited by applicant]
US 6514718B2 · Heller et al. · 2003 [cited by applicant]
US 6541216B1 · Wilsey et al. · 2003 [cited by applicant]
US 6560471B1 · Heller et al. · 2003 [cited by applicant]
US 6579690B1 · Bonnecaze et al. · 2003 [cited by applicant]
US 6600997B2 · Deweese et al. · 2003 [cited by applicant]
US 6605200B1 · Mao et al. · 2003 [cited by applicant]
US 6605201B1 · Mao et al. · 2003 [cited by applicant]
US 6654625B1 · Say et al. · 2003 [cited by applicant]
US 6676816B2 · Mao et al. · 2004 [cited by applicant]
US 6736957B1 · Forrow · 2004 [cited by applicant]
US 6746582B2 · Heller et al. · 2004 [cited by applicant]
US 6881551B2 · Heller et al. · 2005 [cited by applicant]
US 6932894B2 · Mao et al. · 2005 [cited by applicant]
US 6946299B2 · Neel et al. · 2005 [cited by applicant]
US 7090756B2 · Mao et al. · 2006 [cited by applicant]
US 7299082B2 · Feldman et al. · 2007 [cited by applicant]
US 7501053B2 · Karinka et al. · 2009 [cited by applicant]
US 7520970B2 · Sato et al. · 2009 [cited by applicant]
US 7563588B2 · Gao et al. · 2009 [cited by applicant]
US 7754093B2 · Forrow et al. · 2010 [cited by applicant]
US 7811231B2 · Jin et al. · 2010 [cited by applicant]
US 7822557B2 · Chen et al. · 2010 [cited by applicant]
US 8106780B2 · Goodnow · 2012 [cited by applicant]
US 8268143B2 · Liu et al. · 2012 [cited by applicant]
US 8435682B2 · Heller · 2013 [cited by applicant]
US 8444834B2 · Liu et al. · 2013 [cited by applicant]
US 8545693B2 · Mccoll et al. · 2013 [cited by applicant]
US 8761857B2 · Feldman et al. · 2014 [cited by applicant]
US 8911908B2 · Sakai et al. · 2014 [cited by applicant]
US 9290839B2 · Wang et al. · 2016 [cited by applicant]
US 9775549B2 · Ouyang et al. · 2017 [cited by applicant]
US 9914952B2 · Ouyang et al. · 2018 [cited by applicant]
US 9927386B2 · Wang et al. · 2018 [cited by applicant]
US 9983161B2 · Feldman et al. · 2018 [cited by applicant]
US 10022076B2 · Hoss et al. · 2018 [cited by applicant]
US 10136816B2 · Bernstein et al. · 2018 [cited by applicant]
US 10201301B2 · Heller et al. · 2019 [cited by applicant]
US 10702193B2 · Simpson et al. · 2020 [cited by applicant]
US 11091788B2 · Ouyang et al. · 2021 [cited by applicant]
US 20010003045A1 · Davis et al. · 2001 [cited by applicant]
US 20030042137A1 · Mao et al. · 2003 [cited by applicant]
US 20030050547A1 · Lebel et al. · 2003 [cited by applicant]
US 20030068666A1 · Zweig · 2003 [cited by applicant]
US 20030100821A1 · Heller et al. · 2003 [cited by applicant]
US 20040061232A1 · Shah et al. · 2004 [cited by applicant]
US 20050148832A1 · Reghabi et al. · 2005 [cited by applicant]
US 20050215871A1 · Feldman et al. · 2005 [cited by applicant]
US 20060004272A1 · Shah · 2006 [cited by applicant]
US 20060076236A1 · Shah et al. · 2006 [cited by applicant]
US 20060257996A1 · Simpson et al. · 2006 [cited by applicant]
US 20070007132A1 · Mao et al. · 2007 [cited by applicant]
US 20070027385A1 · Brister et al. · 2007 [cited by applicant]
US 20070042377A1 · Gao et al. · 2007 [cited by applicant]
US 20070095661A1 · Wang et al. · 2007 [cited by applicant]
US 20070131547A1 · Nomoto et al. · 2007 [cited by applicant]
US 20070213611A1 · Simpson et al. · 2007 [cited by applicant]
US 20070235331A1 · Simpson et al. · 2007 [cited by applicant]
US 20070270672A1 · Hayter · 2007 [cited by applicant]
US 20080179187A1 · Ouyang et al. · 2008 [cited by applicant]
US 20080319295A1 · Bernstein et al. · 2008 [cited by applicant]
US 20090166194A1 · Sato et al. · 2009 [cited by applicant]
US 20090294306A1 · Feldman · 2009 [cited by examiner]
US 20100185070A1 · Brister et al. · 2010 [cited by applicant]
US 20100198034A1 · Thomas et al. · 2010 [cited by applicant]
US 20100213057A1 · Feldman et al. · 2010 [cited by applicant]
US 20100230285A1 · Hoss et al. · 2010 [cited by applicant]
US 20100267161A1 · Wu et al. · 2010 [cited by applicant]
US 20100268043A1 · Yodfat et al. · 2010 [cited by applicant]
US 20100324392A1 · Yee et al. · 2010 [cited by applicant]
US 20100326842A1 · Mazza et al. · 2010 [cited by applicant]
US 20110039165A1 · Sugiyama et al. · 2011 [cited by applicant]
US 20110046467A1 · Simpson et al. · 2011 [cited by applicant]
US 20110065008A1 · Nakagawa et al. · 2011 [cited by applicant]
US 20110120865A1 · Bommakanti et al. · 2011 [cited by applicant]
US 20110124993A1 · Bommakanti et al. · 2011 [cited by applicant]
US 20110124994A1 · Bommakanti et al. · 2011 [cited by applicant]
US 20110126188A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110213057A1 · Fenn et al. · 2011 [cited by applicant]
US 20110213225A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110256024A1 · Cole et al. · 2011 [cited by applicant]
US 20110257495A1 · Hoss et al. · 2011 [cited by applicant]
US 20120132525A1 · Liu et al. · 2012 [cited by applicant]
US 20120138484A1 · Bommakanti et al. · 2012 [cited by applicant]
US 20120150005A1 · Hoss · 2012 [cited by examiner]
US 20120157801A1 · Hoss et al. · 2012 [cited by applicant]
US 20120181189A1 · Merchant · 2012 [cited by applicant]
US 20120186997A1 · Li et al. · 2012 [cited by applicant]
US 20120245447A1 · Karan et al. · 2012 [cited by applicant]
US 20120283537A1 · Petisce et al. · 2012 [cited by applicant]
US 20120296186A1 · Ouyang et al. · 2012 [cited by applicant]
US 20120323098A1 · Moein et al. · 2012 [cited by applicant]
US 20130059212A1 · Kusumegi et al. · 2013 [cited by applicant]
US 20130116524A1 · Cole et al. · 2013 [cited by applicant]
US 20130131478A1 · Simpson et al. · 2013 [cited by applicant]
US 20130211219A1 · Coppeta et al. · 2013 [cited by applicant]
US 20130231542A1 · Simpson et al. · 2013 [cited by applicant]
US 20130245412A1 · Rong et al. · 2013 [cited by applicant]
US 20130324820A1 · Petillo et al. · 2013 [cited by applicant]
US 20140054171A1 · Feldman et al. · 2014 [cited by applicant]
US 20140127728A1 · Wilsey · 2014 [cited by applicant]
US 20140176338A1 · He et al. · 2014 [cited by applicant]
US 20140262776A1 · Martin · 2014 [cited by examiner]
US 20140262777A1 · Zhao · 2014 [cited by examiner]
US 20150038814A1 · Staib et al. · 2015 [cited by applicant]
US 20150076004A1 · Gerber et al. · 2015 [cited by applicant]
US 20150207796A1 · Love et al. · 2015 [cited by applicant]
US 20160045147A1 · Ouyang et al. · 2016 [cited by applicant]
US 20160319232A1 · Noritomi et al. · 2016 [cited by applicant]
US 20160328991A1 · Simpson et al. · 2016 [cited by applicant]
US 20160345882A1 · Wu et al. · 2016 [cited by applicant]
US 20160354542A1 · Ward et al. · 2016 [cited by applicant]
US 20160355862A1 · Deng et al. · 2016 [cited by applicant]
US 20170156652A1 · Qiang · 2017 [cited by applicant]
US 20170191958A1 · Gerber et al. · 2017 [cited by applicant]
US 20170202491A1 · Heller et al. · 2017 [cited by applicant]
US 20170315077A1 · Rao et al. · 2017 [cited by applicant]
US 20170319111A1 · Simpson et al. · 2017 [cited by applicant]
US 20180014766A1 · Ouyang et al. · 2018 [cited by applicant]
US 20180116604A1 · Newberry · 2018 [cited by applicant]
US 20180275088A1 · Huff et al. · 2018 [cited by applicant]
US 20190004005A1 · Oja et al. · 2019 [cited by applicant]
US 20190024130A1 · Ouyang et al. · 2019 [cited by applicant]
US 20190125230A1 · Feldman · 2019 [cited by applicant]
US 20190271658A1 · Haneda et al. · 2019 [cited by applicant]
US 20190274598A1 · Scott · 2019 [cited by examiner]
US 20190320947A1 · Chen et al. · 2019 [cited by applicant]
US 20200069226A1 · Hahn · 2020 [cited by examiner]
US 20200237275A1 · Feldman et al. · 2020 [cited by applicant]
US 20200237276A1 · Oja et al. · 2020 [cited by applicant]
US 20200237277A1 · Ouyang et al. · 2020 [cited by applicant]
US 20210137431A1 · Oja et al. · 2021 [cited by applicant]
US 20220056500A1 · Ouyang et al. · 2022 [cited by applicant]
US 20220168727A1 · Baldwa · 2022 [cited by examiner]
US 20220386910A1 · Oja et al. · 2022 [cited by applicant]
US 20220389475A1 · Ouyang et al. · 2022 [cited by applicant]
US 20220395202A1 · Ouyang et al. · 2022 [cited by applicant]
US 20220396820A1 · Ouyang et al. · 2022 [cited by applicant]
US 20230054564A1 · Ouyang et al. · 2023 [cited by applicant]
US 20230080107A1 · Ouyang et al. · 2023 [cited by applicant]
US 20230118818A1 · Feldman et al. · 2023 [cited by applicant]
US 20230119512A1 · Feldman et al. · 2023 [cited by applicant]
US 20230121101A1 · Feldman et al. · 2023 [cited by applicant]
US 20230121367A1 · Feldman et al. · 2023 [cited by applicant]
US 20230121769A1 · Feldman et al. · 2023 [cited by applicant]
US 20230122702A1 · Feldman et al. · 2023 [cited by applicant]
US 20230123384A1 · Feldman et al. · 2023 [cited by applicant]
US 20230128038A1 · Feldman et al. · 2023 [cited by applicant]
US 20240247297A1 · Ouyang et al. · 2024 [cited by applicant]
US 20240350047A1 · Oja et al. · 2024 [cited by applicant]
US 20250221643A1 · Ouyang et al. · 2025 [cited by applicant]
US 20250261884A1 · Oja et al. · 2025 [cited by applicant]
US 20260002188A1 · Ouyang et al. · 2026 [cited by applicant]
US 20260002189A1 · Ouyang et al. · 2026 [cited by applicant]
US 20260002190A1 · Ouyang et al. · 2026 [cited by applicant]
US 20260002191A1 · Ouyang et al. · 2026 [cited by applicant]
US 20260002192A1 · Ouyang et al. · 2026 [cited by applicant]
US 20260002193A1 · Ouyang et al. · 2026 [cited by applicant]
US 20260020797A1 · Oja et al. · 2026 [cited by applicant]
US 20260020798A1 · Oja et al. · 2026 [cited by applicant]
US 20260020799A1 · Oja et al. · 2026 [cited by applicant]
CN 1735375A · 2006 [cited by applicant]
CN 101849180B · 2017 [cited by applicant]
CN 113164106A · 2021 [cited by applicant]
EP 000409435A1 · 1991 [cited by applicant]
EP 0990706A1 · 2000 [cited by applicant]
EP 3394252A1 · 2018 [cited by applicant]
EP 3414325A1 · 2018 [cited by applicant]
EP 3597765A1 · 2020 [cited by applicant]
EP 4084689A1 · 2022 [cited by applicant]
GB 2067764A · 1981 [cited by applicant]
JP 03053896A · 1991 [cited by applicant]
JP 2001506742A · 2001 [cited by applicant]
JP 2007510155A · 2007 [cited by applicant]
JP 2007290504A · 2007 [cited by applicant]
JP 2008516235A · 2008 [cited by applicant]
JP 2010517054A · 2010 [cited by applicant]
JP 2010530790A · 2010 [cited by applicant]
JP 2011136186A · 2011 [cited by applicant]
JP 2013504053A · 2013 [cited by applicant]
JP 2014503080A · 2014 [cited by applicant]
JP 2014160024A · 2014 [cited by applicant]
JP 2015198960A · 2015 [cited by applicant]
JP 2018029983A · 2018 [cited by applicant]
JP 2019039817A · 2019 [cited by applicant]
JP 2022172249A · 2022 [cited by applicant]
WO WO03056319A2 · 2003 [cited by applicant]
WO WO2005040404A1 · 2005 [cited by applicant]
WO WO2006042001A2 · 2006 [cited by applicant]
WO WO2008041984A1 · 2008 [cited by applicant]
WO WO2009105337A2 · 2009 [cited by applicant]
WO WO2010030912A1 · 2010 [cited by applicant]
WO WO2011030093A1 · 2011 [cited by applicant]
WO WO2012100130A1 · 2012 [cited by applicant]
WO WO2015150263A1 · 2015 [cited by applicant]
WO WO2015195352A1 · 2015 [cited by applicant]
WO WO2016025064A1 · 2016 [cited by applicant]
WO WO2016174456A1 · 2016 [cited by applicant]
WO WO2016174458A1 · 2016 [cited by applicant]
WO WO2017151952A1 · 2017 [cited by applicant]
WO WO2018067235A1 · 2018 [cited by applicant]
WO WO2018106129A1 · 2018 [cited by applicant]
WO WO2019006413A1 · 2019 [cited by applicant]
T. Monteiro, P.R. Rodrigues, A. L. Gonçalves, J.J.G. Moura, E. Jubete, L. Añorga, B. Piknova, A.N. Schechter, C.M. Silveira, M. G. Almeida, “Construction of effective disposable biosensors for point of care testing of n… [cited by examiner]
Guiseppi-Elie et al, “Design of a Subcutaneous Implantable Biochip for Monitoring of Glucose and Lactate,” IEEE Sensors Journal, Jun. 1, 2005. [cited by applicant]
C.S. Pundir et al, “Biosensing Methods for Determination of Creatinine: A Review,” Biosensors and Bioelectronics Journal, Nov. 19, 2018. [cited by applicant]
ISRWO in corresponding PCT/US2019/052942 with mail date Nov. 28, 2019. [cited by applicant]
Cardosi, M., et al., “Amperometric Glucose Sensors for Whole Blood Measurement Based on Dehydrogenase Enzymes,” in Dehydrogenases, InTech, United Kingdom (Nov. 2012). [cited by applicant]
Office Action mailed Apr. 18, 2022 in U.S. Appl. No. 16/774,835, Feldman, B., et al., filed Jan. 28, 2020, 24 pages. [cited by applicant]
Office Action mailed Jun. 2, 2022 in U.S. Appl. No. 16/774,909, Ouyang, T., et al., filed Jan. 28, 2020, 13 pages. [cited by applicant]
Office Action mailed Jun. 24, 2022 in U.S. Appl. No. 16/774,841, Oja, S., et al., filed Jan. 28, 2020, 10 pages. [cited by applicant]
Office Action mailed Sep. 17, 2022 in U.S. Appl. No. 16/774,835, Feldman, B., et al., filed Jan. 28, 2020, 21 pages. [cited by applicant]
Office Action mailed Dec. 21, 2022 in U.S. Appl. No. 16/774,909, Ouyang, T., et al., filed Jan. 28, 2020, 13 pages. [cited by applicant]
Office Action mailed Nov. 25, 2022 in U.S. Appl. No. 17/151,274, Oja, S., et al., filed Jan. 18, 2021, 13 pages. [cited by applicant]
Office Action mailed Mar. 2, 2023 in U.S. Appl. No. 16/774,835, 14 pages. [cited by applicant]
Office Action mailed Aug. 8, 2023 in U.S. Appl. No. 16/774,909, 15 pages. [cited by applicant]
Office Action mailed Nov. 16, 2022 in U.S. Appl. No. 16/774,841, 11 pages. [cited by applicant]
D'Allegro, Joe, “Soon Your Car Will Know When You Are Having a Heart Attack—and Know How to React”, CNBC, Nov. 17, 2017, https://www.cnbc.com/2017/11/17/cars-will-know-when-youre-having-a-beart-attack-and-how-to-react.h… [cited by applicant]
Burmeister, J.J., and Gerhardt, G.A., “Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes,” Anal. Chem. 73(… [cited by applicant]
Mueller, S., et al., “The GOX/CAT system: a novel enzymatic method to independently control hydrogen peroxide and hypoxia in cell culture,” Adv. Med. Sci. 54(2):121-135, Elsevier, Netherlands (2009). [cited by applicant]
Shi, G., et al., “The study of Nafion/xanthine oxidase/Au colloid chemically modified biosensor and its application in the determination of hypoxanthine in myocardial cells in vivo,” Analyst 127(3):396-400, Royal Societ… [cited by applicant]
Office Action mailed Sep. 12, 2023 in U.S. Appl. No. 16/774,835, 16 pages. [cited by applicant]
Notice of Allowance mailed Aug. 16, 2023 in U.S. Appl. No. 16/774,841, 8 pages. [cited by applicant]
Office Action mailed Sep. 7, 2023 in U.S. Appl. No. 17/151,274, 13 pages. [cited by applicant]
Office Action mailed Sep. 21, 2023 in U.S. Appl. No. 17/819,099, 24 pages. [cited by applicant]
Alva, S., et al., “Feasibility of Continuous Ketone Monitoring in Subcutaneous Tissue Using a Ketone Sensor,” Journal of Diabetes Science and Technology 15(4):768-774, Sage, United States (Jul. 2021). [cited by applicant]
D'Allegro, J., “Soon your car will know when you are having a heart attack and know how to react,” Modem Medicine, CNBC, Accessed at https://www.cnbc.com/2017/11/17/cars-will-know-when-youre-having-a-heart-attack-and-ho… [cited by applicant]
Del Cano, R., et al., Ketone Bodies Detection: Wearable and Mobile Sensors for Personalized Medicine an Nutrition, Trends in Analytical Chemistry 159:116938, (Feb. 2023), 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/138,477, mailed on Apr. 3, 2024, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/138,477, mailed on Mar. 17, 2023, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/403,258, mailed on Nov. 13, 2024, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/818,143 mailed on Jul. 30, 2024, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/818,770 mailed on Jul. 30, 2024, 13 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/081,162, mailed on Dec. 30, 2020, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/818,912, mailed on Oct. 25, 2024, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/819,038, mailed on Aug. 26, 2024, 10 pages. [cited by applicant]
Franco, J.H., et al., “Product Analysis of Operating an Ethanol/O2 Biofuel Cell Shows the Synergy between Enzymes within an Enzymatic Cascade,” Journal of The Electrochemical Society 165(9):H575-H579, (2018). [cited by applicant]
International Search Report and Written Opinion for PCT/US2017/020495, mailed on Jul. 10, 2017, 23 pages. [cited by applicant]
Kowalewska, B., and Kulesza, P.J., “Toward More Efficient Bioelectrocatalytic Oxidation of Ethanol for Amperometric Sensing and Biofuel Cell Technology,” Analytical Chemistry 84(21):9564-9571, American Chemical Society,… [cited by applicant]
Nakabayashi, Y., et al., “Evaluation of Osmium(II) Complexes as Electron Transfer Mediators Accessible for Amperometric Glucose Sensors,” Analytical Sciences 17(8):945-950, Springer, Switzerland (Aug. 2001). [cited by applicant]
Nikitina, O., et al., “Bi-enzyme Biosensor Based on NAD+− and Glutathione-dependent Recombinant Formaldehyde Dehydrogenase and Diaphorase for Formaldehyde Assay,” Sensors and Actuators 125(1):1-9, (Jul. 2007). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/081,162 mailed on Jul. 22, 2020, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/138,477. mailed on Aug. 21, 2023, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/138,477, mailed on Sep. 12, 2022, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/403,258 mailed on Mar. 25, 2024, 9 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/818,143 mailed on Jan. 24, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/818,143, mailed on Nov. 14, 2024, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/818,770 mailed on Mar. 12, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/818,770, mailed on Nov. 5, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/818,912 mailed on Apr. 26, 2024, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/819,038 mailed on Jan. 31, 2024, 11 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/819,151 mailed on May 7, 2024, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,704 mailed on Dec. 16, 2025; 49 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/597,704 mailed on Sep. 16, 2024, 09 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/320,168, mailed on Dec. 15, 2025, 8 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/320,172 mailed on Dec. 4, 2025; 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/320,176 mailed on Dec. 3, 2025, 15 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/320,180 mailed on Dec. 16, 2025; 17 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/340,421 mailed on Nov. 28, 2025, 19 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/340,445 mailed on Nov. 28, 2025, 20 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/340,458 mailed on Nov. 28, 2025, 22 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/081,162, mailed on Apr. 13, 2021, 7 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/774,835 mailed on Jan. 20, 2026, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/818,143, mailed on Jan. 21, 2026, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/818,143 mailed on Oct. 28, 2025; 7 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/819,151, mailed on Oct. 22, 2024, 7 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/068,072, mailed on Jan. 23, 2026, 5 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/068,860, mailed on Jan. 22, 2026, 5 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/596,447, mailed on Jan. 21, 2026, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/597,704 mailed on Jan. 27, 2026, 7 pages. [cited by applicant]
Pickup, J.C., “Glucose Sensors: Present and Future,” International Textbook of Diabetes Mellitus, Third Edition, Defronzo, R.A., eds., 2:1686-1694, John Wiley & Sons Inc., United States (2004), 13 Pages. [cited by applicant]
Zhang, J.Y., et al., “Continuous Ketone Monitoring: A New Paradigm for Physiologic Monitoring,” Journal of Diabetes Science and Technology 15(4):775-780, Sage, United States (Jul. 2021). [cited by applicant]
Final Office Action for U.S. Appl. No. 16/774,909 mailed on Apr. 9, 2024, 13 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/015365, mailed May 28, 2020, 14 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/015400, mailed on Apr. 9, 2020, 14 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/015321, mailed on Apr. 9, 2020, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/774,835 mailed on Apr. 15, 2024, 16 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/819,099 mailed on Mar. 5, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,019 mailed on Feb. 29, 2024, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,072 mailed on Feb. 15, 2024, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,077 mailed on Jul. 30, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,704 mailed on Jun. 18, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,714 mailed on Mar. 5, 2024, 14 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,834 mailed on Jan. 31, 2024, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,860 mailed on Jul. 15, 2024, 13 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/151,274 mailed on Feb. 7, 2024, 8 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/774,835 mailed on Dec. 24, 2024, 25 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/774,909 mailed on Sep. 29, 2024, 10 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/774,909 mailed on Dec. 27, 2024, 7 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/068,072 mailed on Oct. 18, 2024, 13 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/068,077 mailed on Jan. 28, 2025, 26 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/068,019 mailed on Oct. 17, 2024, 17 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/068,704 mailed on Jan. 24, 2025, 16 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/068,714 mailed on Oct. 18, 2024, 15 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/068,860 mailed on Oct. 18, 2024, 15 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,834 mailed on Oct. 18, 2024, 15 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/068,807 mailed on Jan. 29, 2025, 25 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/774,841 mailed on Feb. 9, 2024, 3 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/819,099 mailed on Jul. 9, 2024, 8 pages. [cited by applicant]